|
21
|
Tolstikova T.G.
, Bryzgalov A.O.
, Sorokina I.V.
, Dolgikh M.P.
, Shul'ts E.E.
, Osadchii S.A.
, Tolstikov G.A.
Formation of salts with hydrobromic acid determines the antiarrhythmic effect of lappaconitine derivatives
Doklady Biological Sciences. 2007.
V.415. N1. P.265-266. DOI: 10.1134/S0012496607040047
Scopus
РИНЦ
OpenAlex
|
|
22
|
Tolstikova T.G.
, Bryzgalov A.O.
, Sorokina I.V.
, Ratushnyak A.S.
, Zapara T.A.
, Simonova O.G.
, Tolstikov G.A.
To the nature of the effect of glycosidic clathration of pharmacons
Doklady Biological Sciences. 2007.
V.416. N1. P.336-337. DOI: 10.1134/S0012496607050031
Scopus
РИНЦ
OpenAlex
|
|
23
|
Bryzgalov A.
, Dolgikh M.
, Sorokina I.
, Tolstikova T.
, Sedova V.
, Shkurko O.
Antiarrhythmic activity of 4,6-di(het)aryl-5-nitro-3,4-dihydropyrimidin-(1 H)-2-ones and its effects on arterial pressure in rats
Bioorganic and Medicinal Chemistry Letters. 2006.
V.16. N5. P.1418-1420. DOI: 10.1016/j.bmcl.2005.11.043
WOS
Scopus
РИНЦ
OpenAlex
|
|
24
|
Tolstikova T.G.
, Bryzgalov A.O.
, Sorokina I.V.
, Morozova E.A.
, Tolstikov S.E.
, Al'fonsov A.V.
, Tolstikov A.G.
Stevioside is a novel stimulator of pharmacon clathration with glycosides
Doklady Biological Sciences. 2005.
V.403. N1-6. P.244-246. DOI: 10.1007/s10630-005-0100-3
Scopus
РИНЦ
OpenAlex
|
|
25
|
Bryzgalov A.O.
, Volkova E.B.
, Ganenko Y.A.
, Dolgikh M.P.
, Zhukova N.A.
, Sorokina I.V.
, Tolstikova T.G.
Antiarrhythmic activity of alaglyzin [Антиаритмическая активность алаглизина]
Экспериментальная и клиническая фармакология/Eksperimental'naya i Klinicheskaya Farmakologiya. 2005.
V.68. N4. P.24-27.
Scopus
РИНЦ
|
|
26
|
Tolstikova T.G.
, Bryzgalov A.O.
, Sorokina I.V.
, Morozova E.A.
, Tolstikov S.E.
, Al'fonsov A.V.
, Tolstikov A.G.
Stevioside - a new simulator of effect of clathration of pharmacons by glycosides
Доклады академии наук. 2005.
V.403. N2. P.274-276.
Scopus
РИНЦ
|
|
27
|
Tolstikova T.G.
, Bryzgalov A.O.
, Sorokina I.V.
, Tolstikov S.E.
, Kovalenko I.L.
, Avgustinovich D.F.
New approach to development of low-dose CNS-active drug
EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2005.
V.15. P.S125. DOI: 10.1016/S0924-977X(05)80268-8
WOS
OpenAlex
|